Methods and compositions for enhanced transmucosal delivery of peptides and proteins
AssigneeAmylin Pharmaceuticals, Inc.
InventorsJohn Ong, Robert Jennings, Gregg Stetsko
Life of this patent
Estimating the term…
Abstract
Provided are methods and compositions for enhancing the transmucosal absorption of bioactive peptides and proteins. More particularly, the invention provides compositions for enhancing the transmucosal absorption of bioactive peptides and proteins, such as exendin-4, PYY, PYY3-36, and GLP-1 and their analogs and derivatives, wherein the compositions comprise an absorption enhancing mixture of a cationic polyamino acid and a buffer that is compatible with the polyamino acid. Also provided are methods for enhancing the transmucosal absorption and bioavailability of bioactive peptides and proteins using such compositions.
Claims8
A pharmaceutical composition for transmucosal administration comprising about 0.5% (w/v) of exendin-4;
- about 0.5% (w/v) of poly-arginine having an average molecular weight of about 141 kDa;
- and about 0.56% monosodium glutamate monohydrate (w/v), at a pH of about 4.5 and wherein the exendin-4 has the same net charge as the poly-arginine at the pH of the composition.
A pharmaceutical composition for transmucosal administration comprising about 0.5% (w/v) of exendin-4;
- about 1.0% (w/v) of poly-arginine having an average molecular weight of about 141 kDa;
- and about 0.56% monosodium glutamate monohydrate (w/v), at a pH of about 4.5 and wherein the exendin-4 has the same net charge as the poly-arginine at the pH of the composition.
Dependencies are inferred from the claim text.